Document is current
Any future updates will be listed below
-
Authors
Rueda, Ariana
Serna, Naroa
Mangues, Ramon
Villaverde, Antonio
Unzueta, Ugutz
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FI21/00012, PI21/00150, PI20/00400)
Agencia Española de Investigación (PID2020-116174RB-I00)
- License Information
-
More Information
Article History
Received: 3 February 2025
Accepted: 13 April 2025
First Online: 1 May 2025
Declarations
:
: Not applicable.
: All authors have revised the final version and consent article publication.
: R.M., A.V. and U.U. are listed as inventors in a patent covering the use of T22-empowered nanoparticles for CXCR4-targeted nanomedicine.
